When patients request drugs for nonmedical reasons, the most effective intervention may be to explore with the patient his or her reasons for using drugs to make lifestyle changes.
The current Medicare operation—reimbursing medical goods and services to a growing number of people without basing the reimbursement benefit on the actual cost of the services—is unsustainable, but there are some possible remedies.
The organ transplantation system is viewed as one of our most equitable health care services, but poor patients are effectively excluded by policy that denies Medicaid coverage of post-transplant immunosuppressant medication.
A medical student's perspective on the importance of empathy in patient-physician relationships and a reflection on how empathy was taught in his medical school.
Richard L. Kravitz, MD, MSPH and Jodi Halpern, MD, PhD
Patients have a responsibility to discerningly present the drug information they receive from direct-to-consumer advertising and to be active partners with their physician in making health care decisions.
Physicians are cautioned that the two obstacles to reforming post-marketing clinical trials are the FDA's reluctance to revisit past approvals and its inability to enforce pharmaceutical companies' commitment to conduct Phase IV trials.
The concept stewardship borrows from collective action problems that cannot be solved by individuals only, just like those discussed in environmental ethics.
AMA J Ethics. 2024;26(6):E479-485. doi:
10.1001/amajethics.2024.479.
Dr Keith W. Hamilton joins Ethics Talk to discuss his article, coauthored with Dr George Maliha, Keith Robert Thomas, and Mary Ellen Nepps: “How Might Antibiotic Stewardship Programs Influence Clinicians’ Autonomy and Organizations’ Liability?”